Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

BACKGROUND: No biomarker exists to guide the optimal choice of chemotherapy for patients with metastatic colorectal cancer. We examined the copy numbers (CN) of topoisomerase I (TOP1) as well as the ratios of TOP1/CEN-20 and TOP1/CEN-2 as biomarkers for irinotecan efficacy in patients with metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Palshof, Jesper Andreas, Høgdall, Estrid Vilma Solyom, Poulsen, Tim Svenstrup, Linnemann, Dorte, Jensen, Benny Vittrup, Pfeiffer, Per, Tarpgaard, Line Schmidt, Brünner, Nils, Stenvang, Jan, Yilmaz, Mette, Nielsen, Dorte Lisbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225543/
https://www.ncbi.nlm.nih.gov/pubmed/28077117
http://dx.doi.org/10.1186/s12885-016-3001-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225543/
https://www.ncbi.nlm.nih.gov/pubmed/28077117
http://dx.doi.org/10.1186/s12885-016-3001-y

Ejemplares similares